On univariable analysis, the significant factors associated with CMV infection at 6 months post-transplant were pre-transplant PRA (HR 1.02, p = 0.001), ATG induction therapy (HR 3.04, 95% CI 1.53–6.06, p = 0.002), and IFN-γ ELISpot <250 SFUs/2.5 × 105 PBMCs (HR 3.30, 95% CI 1.36–8.03, p = 0.008). Here, IFNG is linked to cytomegalovirus infection.